<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInsurance_company_valuation</id>
	<title>Definition:Insurance company valuation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInsurance_company_valuation"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_company_valuation&amp;action=history"/>
	<updated>2026-06-13T15:13:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_company_valuation&amp;diff=15618&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_company_valuation&amp;diff=15618&amp;oldid=prev"/>
		<updated>2026-03-14T17:39:04Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏦 &amp;#039;&amp;#039;&amp;#039;Insurance company valuation&amp;#039;&amp;#039;&amp;#039; is the process of estimating the economic worth of an [[Definition:Insurance carrier | insurance carrier]] or [[Definition:Insurance holding company | insurance group]], drawing on methodologies tailored to the distinctive financial structure of insurers — where liabilities are uncertain, revenue is collected before costs are known, and regulatory capital regimes heavily influence distributable earnings. Standard corporate valuation techniques such as discounted cash flow analysis require significant adaptation for insurance, because an insurer&amp;#039;s &amp;quot;inventory&amp;quot; consists of [[Definition:Reserve | reserves]] against future [[Definition:Claim | claims]] rather than physical assets, and the timing and magnitude of those claims may not be known for years or even decades.&lt;br /&gt;
&lt;br /&gt;
⚙️ Practitioners rely on several valuation frameworks depending on the type of insurer and the market context. For [[Definition:Property and casualty insurance | property and casualty]] carriers, price-to-[[Definition:Book value | book value]] multiples and price-to-earnings ratios remain foundational, supplemented by detailed analysis of reserve adequacy, [[Definition:Combined ratio | combined ratio]] trends, and [[Definition:Investment portfolio | investment portfolio]] quality. Life insurers and composite groups, particularly in Europe and Asia, are more commonly assessed using [[Definition:Embedded value | embedded value]] or its refinements — Market Consistent Embedded Value (MCEV) and European Embedded Value (EEV) — which attempt to capture the present value of future profits locked into the existing book of policies. The introduction of [[Definition:IFRS 17 | IFRS 17]] has reshaped how insurance contract liabilities and revenue appear on financial statements across many jurisdictions, altering the inputs that feed valuation models and prompting analysts to recalibrate long-standing benchmarks. In [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] transactions, acquirers may also perform [[Definition:Actuarial | actuarial]] appraisals that project statutory earnings and capital releases under the regulatory regime governing the target — whether [[Definition:Solvency II | Solvency II]], the [[Definition:Risk-based capital (RBC) | RBC]] framework, [[Definition:C-ROSS | C-ROSS]], or local equivalents.&lt;br /&gt;
&lt;br /&gt;
💡 Getting valuation right carries high stakes across the insurance ecosystem. [[Definition:Private equity | Private equity]] firms that have become major acquirers of life and annuity blocks need precise liability modeling to avoid overpaying for portfolios whose true cost only emerges over decades. [[Definition:Reinsurance | Reinsurers]] evaluating [[Definition:Loss portfolio transfer (LPT) | loss portfolio transfers]] or [[Definition:Adverse development cover (ADC) | adverse development covers]] must price the tail risk embedded in legacy reserves. For publicly traded insurers, the gap between market capitalization and intrinsic value often triggers activist investor campaigns or management buyouts. And in [[Definition:Insurance resolution | resolution]] or [[Definition:Run-off | run-off]] scenarios, regulators depend on accurate valuations to determine whether a troubled carrier can meet its [[Definition:Policyholder | policyholder]] obligations or requires intervention. Because insurance valuation blends financial analysis, [[Definition:Actuarial science | actuarial science]], and regulatory expertise, it remains one of the most specialized disciplines in corporate finance.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Insurance company stock]]&lt;br /&gt;
* [[Definition:Embedded value]]&lt;br /&gt;
* [[Definition:Book value]]&lt;br /&gt;
* [[Definition:IFRS 17]]&lt;br /&gt;
* [[Definition:Mergers and acquisitions (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Actuarial appraisal]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>